# A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated

> **NCT04540874** · PHASE1 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 894416
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04540874
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-05
- **Primary completion:** 2020-11-12
- **Final completion:** 2020-11-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** due to company decision
- **Last updated:** 2023-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04540874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04540874, "A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04540874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*